top of page

Covid-19 Vaccine

The Food and Drug Administration’s decision Monday to grant full approval to Pfizer-BioNTech's two-dose Covid-19 vaccine pushed markets higher, boosting the Dow Jones Industrial Average by 300 points and propelling the S&P 500 and the Nasdaq to new highs. Investors appeared to express confidence that the move could be an inflection point for the economic recovery.


bottom of page